Phase I study of sorafenib combined with radiation therapy and temozolomide as first-line treatment of high-grade glioma

Publication

Phase I study of sorafenib combined with radiation therapy and temozolomide as first-line treatment of high-grade glioma

Journal Paper/Review - Jan 9, 2018

Hottinger A F, Bodmer A, Weber D C, Schaller K, Mach N, Hundsberger Thomas, Vargas M I, Dunkel N, Squiban D, Espeli V, Ben Aissa A, Dietrich P-Y

Citation

Hottinger A, Bodmer A, Weber D, Schaller K, Mach N, Hundsberger T, Vargas M, Dunkel N, Squiban D, Espeli V, Ben Aissa A, Dietrich P. Phase I study of sorafenib combined with radiation therapy and temozolomide as first-line treatment of high-grade glioma. Br J Cancer 2018

Type

Journal Paper/Review (English)

Journal

Br J Cancer 2018

Publication Date

Jan 9, 2018

Issn Electronic

1532-1827

Brief description/objective

This corrects the article DOI: 10.1038/bjc.2014.209.